Published October 19, 2021
20 Ochsner Researchers Rank Among the Top 2% in Their Fields Worldwide
NEW ORLEANS, La. – Twenty Ochsner Health have earned the honor of being labeled in the top 2% of their fields worldwide, according to a significant Stanford University study that ranks researchers based on the impact of their publications. The distinction reinforces Ochsner’s commitment to excellence and innovation in healthcare, education, and research, with a mission to lead and to serve.
The ranking, considered the most prestigious worldwide, measures academic achievement based on bibliometric information and includes more than 160,000 researchers from the more than 8 million scientists considered to be active around the globe. Altogether, 22 scientific fields and 176 subfields are considered in the list.
“We are thrilled that 20 of our physicians from across the Ochsner Health system have been recognized in this illustrious and influential group of researchers,” said W. Mark Roberts, MD, MMM, Dean of Research at Ochsner Health. “As a system that boasts having the top-ranked hospital in Louisiana, Ochsner continually proves its dedication to medical innovation and to improving outcomes for communities in our neighborhoods and beyond.”
The Stanford database is divided into two categories: career-long citation impact and single-year impact, based on the publication released in 2021. In total, 20 Ochsner researchers appear on one or both lists. The first is based on the number of times a scholar's work is cited throughout their career. Seventeen Ochsner researchers from Ochsner Health System, Ochsner Medical Center, Ochsner Baptist Medical Center and Ochsner Heart and Vascular Institute were included in this category, for work that dates back to 1954. For the single-year impact, 12 Ochsner faculty were recognized.
Earning a place among the world’s top 2% of scientists ranked in their subfields over 20 years are the following Ochsner researchers:
- Ronald Amedee, MD, Dean of Medical Education for Ochsner Health and Director of Ochsner Clinical School
- Lawrence Blonde, MD, Director, Ochsner Diabetes Clinical Research Unit
- Edward Bluth, MD, Diagnostic Radiology Specialist
- S.B. Deitelzweig, MD, System Department Chair of Hospital Medicine and Vice President of Medical Affairs for Ochsner Health
- Stephen Fortunato, MD, a Women's Health Medicine Specialist
- Edward Frohlich, MD, Alton Ochsner Distinguished Scientist at Ochsner Clinic Foundation
- David Gellinger Kline, MD, a Specialist in Cardiovascular Disease and Internal Medicine
- Carl “Chip” Lavie, MD, Ochsner’s Medical Director of Cardiac Rehabilitation and Prevention
- Richard Milani, MD, Chief Clinical Transformation Officer at Ochsner Health
- Juan Ochoa, MD, Director, Surgical Intensive Care Unit at Ochsner Medical Center
- George Pankey, MD, Ochsner’s Director of Infectious Diseases Research
- Richard Eugene Ramsay, MD, a Neurology Specialist at Ochsner Health
- Richard Re, MD, Section Head of Hypertension at Ochsner Health
- Armin Schubert, MD, Vice President for Medical Affairs, Quality and Patient Safety at Ochsner Medical Center
- Gabriel Uwaifo, MD, Endocrinology, Diabetes & Metabolism Specialist
- Hector Ventura, MD, Section Head Heart Failure and Heart Transplant at Ochsner Clinic Foundation
- Christopher White, System Chairman for Cardiovascular Disease and Director, John Ochsner Heart & Vascular Institute
Earning a place among the world’s top 2% of scientists ranked in the 2021 report are the following Ochsner researchers:
- J.R. Biggio, MD, System Chair, Women’s Services and System Chair, Maternal-Fetal Medicine at Ochsner Baptist
- Lawrence Blonde, MD, Director, Ochsner Diabetes Clinical Research Unit
- S.B. Deitelzweig, MD, System Department Chair of Hospital Medicine and Vice President of Medical Affairs for Ochsner Health
- Edward Frohlich, MD, Alton Ochsner Distinguished Scientist at Ochsner Clinic Foundation
- Carl “Chip” Lavie, MD, Ochsner’s Medical Director of Cardiac Rehabilitation and Prevention
- Edward McCoul, MD, Rhinology Specialist at Ochsner Health
- Richard Milani, MD, Chief Clinical Transformation Officer at Ochsner Health
- George Pankey, MD, Ochsner’s Director of Infectious Diseases Research
- Eboni Price-Haywood, MD, MPH, FACP, Medical Director at Ochsner Xavier Institute for Health Equity and Research (OXIHER)
- Gabriel Uwaifo, MD, Endocrinology, Diabetes & Metabolism Specialist
- Hector Ventura, MD, Section Head Heart Failure and Heart Transplant at Ochsner Clinic Foundation
- Christopher White, System Chairman for Cardiovascular Disease and Director, John Ochsner Heart & Vascular Institute
